View in EDS

Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.

Saved in:
Bibliographic Details
Title: Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
Authors: Ledermann JA; Cancer Research UK and UCL Cancer Trials Centre, University College London and UCL Hospitals, London, UK. Electronic address: j.ledermann@ucl.ac.uk., Embleton AC; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Raja F; University College London Hospitals, London, UK., Perren TJ; St James's Institute of Oncology and Leeds Institute of Cancer Medicine and Pathology, Leeds, UK., Jayson GC; Christie Hospital and University of Manchester, Manchester, UK., Rustin GJS; Mount Vernon Cancer Centre, Northwood, UK., Kaye SB; Royal Marsden Hospital, London, UK., Hirte H; Juravinski Cancer Centre and McMaster University, Hamilton, ON, Canada., Eisenhauer E; Canadian Cancer Trials Group (CCTG) and Queen's University, Kingston, ON, Canada., Vaughan M; Christchurch Hospital, Christchurch, New Zealand., Friedlander M; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia., González-Martín A; Spanish Group for Investigation in Ovarian Cancer (GEICO) and MD Anderson Cancer Center Madrid, Madrid, Spain., Stark D; University of Leeds, Leeds, UK., Clark E; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Farrelly L; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Swart AM; University of East Anglia, Norwich, UK., Cook A; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Kaplan RS; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Parmar MKB; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.
Corporate Authors: ICON6 collaborators
Source: Lancet (London, England) [Lancet] 2016 Mar 12; Vol. 387 (10023), pp. 1066-1074.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27025186
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ledermann+JA%22">Ledermann JA</searchLink>; Cancer Research UK and UCL Cancer Trials Centre, University College London and UCL Hospitals, London, UK. Electronic address: j.ledermann@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Embleton+AC%22">Embleton AC</searchLink>; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Raja+F%22">Raja F</searchLink>; University College London Hospitals, London, UK.<br /><searchLink fieldCode="AU" term="%22Perren+TJ%22">Perren TJ</searchLink>; St James's Institute of Oncology and Leeds Institute of Cancer Medicine and Pathology, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Jayson+GC%22">Jayson GC</searchLink>; Christie Hospital and University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Rustin+GJS%22">Rustin GJS</searchLink>; Mount Vernon Cancer Centre, Northwood, UK.<br /><searchLink fieldCode="AU" term="%22Kaye+SB%22">Kaye SB</searchLink>; Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Hirte+H%22">Hirte H</searchLink>; Juravinski Cancer Centre and McMaster University, Hamilton, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Eisenhauer+E%22">Eisenhauer E</searchLink>; Canadian Cancer Trials Group (CCTG) and Queen's University, Kingston, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Vaughan+M%22">Vaughan M</searchLink>; Christchurch Hospital, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Friedlander+M%22">Friedlander M</searchLink>; Prince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.<br /><searchLink fieldCode="AU" term="%22González-Martín+A%22">González-Martín A</searchLink>; Spanish Group for Investigation in Ovarian Cancer (GEICO) and MD Anderson Cancer Center Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Stark+D%22">Stark D</searchLink>; University of Leeds, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Clark+E%22">Clark E</searchLink>; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Farrelly+L%22">Farrelly L</searchLink>; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Swart+AM%22">Swart AM</searchLink>; University of East Anglia, Norwich, UK.<br /><searchLink fieldCode="AU" term="%22Cook+A%22">Cook A</searchLink>; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Kaplan+RS%22">Kaplan RS</searchLink>; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Parmar+MKB%22">Parmar MKB</searchLink>; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ICON6+collaborators%22">ICON6 collaborators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2016 Mar 12; Vol. 387 (10023), pp. 1066-1074.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27025186
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/S0140-6736(15)01167-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1066
    Titles:
      – TitleFull: Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ledermann JA
      – PersonEntity:
          Name:
            NameFull: Embleton AC
      – PersonEntity:
          Name:
            NameFull: Raja F
      – PersonEntity:
          Name:
            NameFull: Perren TJ
      – PersonEntity:
          Name:
            NameFull: Jayson GC
      – PersonEntity:
          Name:
            NameFull: Rustin GJS
      – PersonEntity:
          Name:
            NameFull: Kaye SB
      – PersonEntity:
          Name:
            NameFull: Hirte H
      – PersonEntity:
          Name:
            NameFull: Eisenhauer E
      – PersonEntity:
          Name:
            NameFull: Vaughan M
      – PersonEntity:
          Name:
            NameFull: Friedlander M
      – PersonEntity:
          Name:
            NameFull: González-Martín A
      – PersonEntity:
          Name:
            NameFull: Stark D
      – PersonEntity:
          Name:
            NameFull: Clark E
      – PersonEntity:
          Name:
            NameFull: Farrelly L
      – PersonEntity:
          Name:
            NameFull: Swart AM
      – PersonEntity:
          Name:
            NameFull: Cook A
      – PersonEntity:
          Name:
            NameFull: Kaplan RS
      – PersonEntity:
          Name:
            NameFull: Parmar MKB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 03
              Text: 2016 Mar 12
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-electronic
              Value: 1474-547X
          Numbering:
            – Type: volume
              Value: 387
            – Type: issue
              Value: 10023
          Titles:
            – TitleFull: Lancet (London, England)
              Type: main
ResultId 1